Carolinas Medical Center

A-GAME Announces Appointment of Thomas Bond, MD, MS as Chief Medical Officer

Retrieved on: 
Thursday, March 21, 2024
Doctor of Medicine, Health, Longevity, Bond, Drink, Intervention, Nutrition, Regenerative medicine, Physician, Education, Patient, Family medicine, University, Athlete, Exercise, Biophysics, Carolinas Medical Center, Sports medicine, Major League Baseball, LSU, Dentistry

ORLANDO, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- A-GAME Beverages Inc. (“A-GAME”), creator of the “ultimate” hydration beverage, is pleased to announce the appointment of Dr. Thomas Bond as Chief Medical Officer.

Key Points: 
  • ORLANDO, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- A-GAME Beverages Inc. (“A-GAME”), creator of the “ultimate” hydration beverage, is pleased to announce the appointment of Dr. Thomas Bond as Chief Medical Officer.
  • Bond will act as the first Chief Medical Officer for A-GAME Beverages and bring years and valuable experience of both clinical and sideline expertise in the field of Sports Medicine.
  • Dr.
  • Bond was recruited to LSU Medical Center in New Orleans as the Chief of Sports Medicine.

BMI OrganBank, Atrium Health and LifeShare Carolinas Partner to Launch Nation's First Organ Banking Technology

Retrieved on: 
Thursday, February 22, 2024
Abdominal surgery, Kidney transplantation, Temperature, Partnership, Transplant, Postal Index Number, Atrium, Carolinas Medical Center, BMI, Organization, Patient, DCD, Kidney, Perfusion, Dentistry

BMI OrganBank™ is developing novel organ perfusion systems with potential to greatly reduce the waitlist for lifesaving organ transplants.

Key Points: 
  • BMI OrganBank™ is developing novel organ perfusion systems with potential to greatly reduce the waitlist for lifesaving organ transplants.
  • Partnership includes early access to BMI technologies, collaboration on product design, clinical studies, clinical integration pilots and an undisclosed capital arrangement.
  • CHARLOTTE, N.C., Feb. 22, 2024 /PRNewswire/ -- Atrium Health's Division of Abdominal Transplant, Carolinas Medical Center (DAT Atrium), LifeShare Carolinas, one of nation's leading Organ Procurement Organizations, and BMI OrganBank, a developer of organ perfusion systems based in Winston-Salem, North Carolina, announced today that their organizations have partnered to develop and launch the nation's first Organ Banking technology, which will greatly expand the possibilities for organ preservation and reconditioning.
  • With this partnership, DAT Atrium and LifeShare Carolinas will be the first clinical organizations to have access to this technology.

agilon health Announces Chief Medical Officer Transition

Retrieved on: 
Thursday, February 8, 2024
Health, Hospitals, Health Technology, Practice Management, Managed Care, General Health, McKinsey & Company, Total care, Johns Hopkins University, University, ACO, Physician, Internal medicine, Massachusetts General Hospital, Hospital, Carolinas Medical Center, CCO, CMO, Research, Pharmaceutical industry

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Benjamin Kornitzer, M.D., will assume a strategic role as special advisor to the company and will transition from his role as chief medical officer (CMO) effective March 1, 2024. agilon health has initiated a comprehensive search process to identify a new CMO.

Key Points: 
  • agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Benjamin Kornitzer, M.D., will assume a strategic role as special advisor to the company and will transition from his role as chief medical officer (CMO) effective March 1, 2024. agilon health has initiated a comprehensive search process to identify a new CMO.
  • Dr. Rao and agilon’s chief clinical officer (CCO), Kevin Spencer, M.D., will co-lead the company’s clinical strategy.
  • He has built a strong team, and we are glad to have him continue as a valued advisor,” said Steve Sell, chief executive officer, agilon health.
  • Dr. Spencer received his medical degree from the University of Texas Health Science Center at Houston and completed his residency at the Carolinas Medical Center in North Carolina.

3M M*Modal AI-powered radiology speech reporting solution is again honored by the #1 Best in KLAS award for the third consecutive year

Retrieved on: 
Wednesday, February 7, 2024
Intelligence, Software, Workflow, Imaging, Health, Research, Environment, HIMSS, Speech, Documentation, CAPD, Google Images, Radiology, Conference, Carolinas Medical Center, Nursing

According to the KLAS report, 3M Fluency for Imaging surpasses all other front-end speech recognition solutions in the diagnostic imaging speech recognition segment.

Key Points: 
  • According to the KLAS report, 3M Fluency for Imaging surpasses all other front-end speech recognition solutions in the diagnostic imaging speech recognition segment.
  • Delivering high accuracy, overall performance and interoperability, 3M Fluency for Imaging is an artificial intelligence (AI)-powered advanced speech understanding and workflow management reporting solution.
  • The 2024 Best in KLAS: Software and Services report recognizes companies that are committed to helping healthcare professionals deliver better patient care.
  • For more information about 3M M*Modal's top ranking radiology speech reporting solutions, visit www.3m.com/imaging .

Stimdia Medical Inc. Initiates FDA Approved IDE Pivotal Trial to Investigate Impact of Neuromuscular Stimulation on Mechanically Ventilated Patients

Retrieved on: 
Tuesday, October 3, 2023
Science, Research, General Health, Health, FDA, Medical Devices, Health Technology, Other Health, Hospice and palliative medicine, Medicine, Inhalation, Atrium Health, Louisiana State University, Carolinas Medical Center, Diaphragm, Neck, Sale, PNS, Patient, Standard of care, Physician, Nursing, Division, ICU, Nursing care plan, Joe Byrd (Cherokee Nation Principal Chief), Trauma, Weaning, Critical Care Medicine (journal), Medical device, Medical imaging, Pharmaceutical industry

Stimdia Medical, a medical device company developing innovative technologies to improve respiratory care, today announced the initiation of its FDA approved pivotal trial to investigate the impact of phrenic nerve stimulation (PNS) on the time to liberate patients from mechanical ventilation.

Key Points: 
  • Stimdia Medical, a medical device company developing innovative technologies to improve respiratory care, today announced the initiation of its FDA approved pivotal trial to investigate the impact of phrenic nerve stimulation (PNS) on the time to liberate patients from mechanical ventilation.
  • The ReInvigorate Study is a randomized, controlled trial that will enroll approximately 420 patients who are receiving mechanical ventilation in the intensive care unit (ICU).
  • Patients will be randomly assigned to receive PNS therapy utilizing Stimdia’s proprietary pdSTIMTM System or standard of care alone.
  • It is great to be able to investigate this new therapy in our patients who are having difficulties regaining independent breathing.

Shockwave Medical Announces U.S. Launch of New Peripheral IVL Catheter

Retrieved on: 
Tuesday, March 14, 2023
Rupture, Carolinas Medical Center, EVAR, S4, IVL, TEVAR, Regulation of tobacco by the U.S. Food and Drug Administration, L6, Artery, Patient, Shock wave, TAVR, Physician, Calcification, Catheter, FDA, Moyamoya disease, Safety, Cardiovascular disease, Food, Medical imaging

SANTA CLARA, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the full U.S. commercial availability of the Shockwave L6 Peripheral IVL Catheter following clearance by the U.S. Food and Drug Administration (FDA).

Key Points: 
  • SANTA CLARA, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the full U.S. commercial availability of the Shockwave L6 Peripheral IVL Catheter following clearance by the U.S. Food and Drug Administration (FDA).
  • The Shockwave L6 catheter is purpose-built to modify calcification in otherwise difficult-to-treat lesions in large peripheral vessels, including the iliac and the common femoral arteries.
  • “The characteristics of the new catheter allow physicians to optimize IVL therapy in large peripheral vessels, which represent over 20% of peripheral interventions performed in the U.S. each year.
  • The Shockwave L6 enhances the company’s peripheral IVL portfolio, extending the size offerings of the Shockwave M5+ and Shockwave S4 catheters, to provide physicians with a choice of catheters optimized for the challenges of infrapopliteal, femoropopliteal and iliac arterial territories.

ApolloMD Expands Leadership as Company Growth Continues

Retrieved on: 
Monday, February 27, 2023
Region, Atrium Health Union, University, Tufts University, Anzac of the Year Award, Chapel Hill, MBA, Erlanger Health System, Oglethorpe University, UNC Lenoir Health Care, Morehouse College, Meharry Medical College, Prisma Health, EMS, Fuqua School of Business, Marshall University, Medical University of South Carolina, Palmetto, Emergency medicine, RVP, Medical College of Georgia, Medical director, Anderson Regional Medical Center, National Association Medical Staff Services, University of North Carolina at Pembroke, Attitude, Education, Carolinas Medical Center, Lincoln Hospital, Medical college, Management, Nursing, Dentistry, Biology, Science

ATLANTA, Feb. 27, 2023 /PRNewswire/ -- ApolloMD's robust growth calls for the extension of clinical leadership roles to champion our dynamic teams in the form of Regional Vice Presidents (RVPs). RVPs are clinical leaders managing a roster of facilities while supporting company operations in other areas. These leaders will work closely with the Regional and Divisional Presidents, and the operations support assigned to the geographic region.

Key Points: 
  • "The need for this added clinical leadership support has become evident as we continue to grow and develop more partnerships," says Yogin Patel, ApolloMD President.
  • Meet the new ApolloMD Regional Vice Presidents:
    Dr. Richard T. Benson II joined ApolloMD in 2017 and immediately proved to be a dynamic leader with an inspirational vision and a knack for developing team unity.
  • As RVP, Dr. Benson approaches this role with that same enthusiasm and continues his mission in service, now on a systems level.
  • He believes that integrating the priorities of medical staff leadership and emergency medicine leadership can prove to be a vital element of success.

NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine

Retrieved on: 
Thursday, April 21, 2022
Online, News, Elective surgery, Carolinas Medical Center, ACDF, Ćorić, Disability, PCF, Spine, Software, NASDAQ, Food, Hospital, Patient, SAN, Trial of the century, Surgeon, Conference, Technology, Company, Bureau of Oceans and International Environmental and Scientific Affairs, Journal, International Society, NuVasive, Rate, Safety, IDE, FDA, Industry, Multimedia, NDI, Birth control, Dentistry, Medical device, MD, Neurosurgery

SAN DIEGO, April 21, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the NuVasive Simplify® Cervical Disc (Simplify Disc) two-level U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study data was recently published in the Journal of Neurosurgery: Spine. The data were utilized in the device's FDA pre-market application for two-level indication approval, which was approved in April 2021.

Key Points: 
  • SAN DIEGO, April 21, 2022 /PRNewswire/ --NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the NuVasive SimplifyCervical Disc (Simplify Disc) two-levelU.S.
  • Food and Drug Administration(FDA) Investigational Device Exemption (IDE) study data was recently published in the Journal of Neurosurgery: Spine .
  • "This peer-reviewed publication adds to the growing body of clinical evidence in support of the Simplify Disc," saidKyle Malone, vice president of Scientific Affairs atNuVasive.
  • The Simplify Disc is part of the NuVasive C360 portfolio , which offers comprehensive, procedurally integrated solutions for the anterior and posterior cervical spine, including ACDF, cTDR and posterior cervical fusion (PCF) procedures.

EmergeOrtho--Triangle Region Welcomes Michael P. Ransone, MD

Retrieved on: 
Tuesday, November 23, 2021
Patient, Triangle, Hip, MD, University, AOA, Goal, Carolinas Medical Center, CSA OrthoCarolina Sportsplex, Rush University Medical Center, Medicine, Alpha Omega Alpha, Quality of life, Medical device

DURHAM, N.C., Nov. 23, 2021 /PRNewswire/ -- EmergeOrthoTriangle Region welcomes Dr. Michael Ransone, who joined the team on August 23, 2021, to the expert orthopedic care team.

Key Points: 
  • DURHAM, N.C., Nov. 23, 2021 /PRNewswire/ -- EmergeOrthoTriangle Region welcomes Dr. Michael Ransone, who joined the team on August 23, 2021, to the expert orthopedic care team.
  • "I am humbled by the opportunity to be able to help patients in the EmergeOrthoTriangle Region keep these, and oftentimes improve them!"
  • "We are thrilled to welcome Dr. Ransone, a Triangle native, to our EmergeOrtho team," says David Musante, M.D.
  • Mike Ransone, MD graduated Summa Cum Laude with his Bachelors of Science degree from North Carolina State University.

Welltower Announces the Completion of Two Next Generation Medical Office Buildings Leased to Atrium Health

Retrieved on: 
Wednesday, April 28, 2021
Atrium Health, Charlotte, North Carolina, Welltower, Atrium, Carolinas Medical Center, AA3, Hospitals, Health care

b'CHARLOTTE, N.C. and TOLEDO, Ohio, April 28, 2021 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) announced today the completion of two recently developed medical office buildings in Charlotte, NC, totaling over 280,000 square feet.

Key Points: 
  • b'CHARLOTTE, N.C. and TOLEDO, Ohio, April 28, 2021 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) announced today the completion of two recently developed medical office buildings in Charlotte, NC, totaling over 280,000 square feet.
  • The properties were delivered in March 2021 and master leased to Atrium Health (Moody\'s: Aa3; S&P: AA-) under a 15-year triple-net lease.
  • The next-generation care provided by Atrium through these facilities will have meaningful and long-term benefits for the population it serves.
  • "The state-of-the-art facilities will serve as an anchor to the mixed-use campus which is located adjacent to Atrium Health\'s flagship Carolinas Medical Center.